Effects of Individualized Homoeopathic intervention in dyslipidemia: An open label randomized controlled exploratory trial - NI

Central Council for Research in Homoeopathy0 个研究点目标入组 126 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Age 30 to 60yrs.
•2.Patients having serum LDL cholesterol levels >160mg/dl.
•3.Willingness to participate in the study.
•4.Controlled hypertensive patients who are on antihypertensive treatment and who fulfill above mentioned 1st, 2nd & 3rd criteria.
•5.Pre diabetic patients with fasting blood sugar >110 and < 126 mg/dl and who fulfill above mentioned 1st, 2nd & 3rd criteria.

•1.Family H/O of coronary heart diseases, hypertriglyceridemia
•2.Past history of any cardiac event.
•3.Any known systemic illness (cancer, hepatic diseases, renal diseases, diabetes, HIV, any abnormality in LFT& KFT).
•4.Patients on corticosteroids and hormonal treatment.
•5.Excessive alcohol intake, who are taking 60 ml in case of males and 30 ml in case of female for last 1 yr.
•6.Unable or unwilling to give informed consent.
•7.Pregnant and lactating mother.

发起方

Central Council for Research in Homoeopathy